Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Lexington, Massachusetts Clinical Trials

A listing of Lexington, Massachusetts clinical trials actively recruiting patient volunteers.

RESULTS

Found (4) clinical trials

Stop-Service to Obviously-Impaired Patrons

The Responsible Retailing Forum (RRF) has developed a community-based program S-STOP (Stop Service To Obviously-Impaired Patrons) that assists communities and their on-premises alcohol establishments to address the problems of over-service of alcoholic beverages. S-STOP is a six-month program, administered by RRF, which: Conducts Pseudo-Intoxicated Mystery Shop (P-I/MS) visits at on-premises ...

Phase N/A

4.65 miles

Learn More »

A Study to Evaluate the Safety (Compared to Iron Sucrose) Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) or who are at risk of development of IDA Secondary Objective: To determine the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) profile of ferumoxytol in pediatric subjects.

Phase

4.65 miles

Learn More »

Habitual Diet and Avocado Trial

Preliminary evidence suggests that consumption of avocados can modulate body weight, food intake and markers of metabolic syndrome and may reduce visceral adiposity. Visceral adipose tissue is positively correlated with risk of cardiometabolic syndrome that predisposes to cardiovascular disease and diabetes. The Habitual Diet and Avocado Trial (HAT) aims to ...

Phase N/A

5.83 miles

Learn More »

North American Prodromal Synucleinopathy Consortium

REM sleep behavior disorder (RBD) is a rare disorder where people act out their dreams. People with RBD often, but not always, develop Parkinson's Disease, dementia with Lewy bodies, multiple system atrophy, or other neurodegenerative diseases of the synucleinopathy type. The North American Prodromal Synucleinopathy (NAPS) Consortium was formed with ...

Phase N/A

7.87 miles

Learn More »